Impact of Mesenchymal Stem Cells in Knee Osteoarthritis

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Musculoskeletal PainKnee OsteoarthritisCartilage InjuryCartilage Degeneration
Interventions
BIOLOGICAL

Autologous Mesenchymal Stem Cells

Bone marrow will be harvested from each individual patient's iliac crest, followed by stem cell isolation, expansion and preparation. Stem cell will be injected approximately 3-4 weeks after bone marrow harvest, injecting 50x10\^6 MSCs in the knee via a medial parapatellar approach under sterile technique in 8 patients with generalized knee OA or focal chondral defects.

Trial Locations (1)

44106

University Hospital Cleveland Medical Center, Cleveland

All Listed Sponsors
collaborator

Case Western Reserve University

OTHER

lead

University Hospitals Cleveland Medical Center

OTHER